Jeremy Grantham's MDT Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 51,116 shares of Medtronic plc (MDT) worth $4.87 M, representing 0.01% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 43 quarters.
Based on 13F filings since 2013, Jeremy Grantham has maintained a long-term strategic position in MDT, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2016, adding 738,166 shares. Largest reduction occurred in Q2 2023, reducing 2.76 M shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Medtronic plc (MDT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medtronic plc (MDT) Trades by Jeremy Grantham
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2015 | +7.4 M | New Buy | 7.4 M | $77.99 |
| Q2 2015 | +142,938 | Add 1.93% | 7.55 M | $74.10 |
| Q3 2015 | -348,342 | Reduce 4.62% | 7.2 M | $66.94 |
| Q4 2015 | -2.65 M | Reduce 36.84% | 4.55 M | $76.92 |
| Q1 2016 | -838,882 | Reduce 18.46% | 3.71 M | $75.00 |
| Q2 2016 | +738,166 | Add 19.91% | 4.44 M | $86.77 |
| Q3 2016 | +148,176 | Add 3.33% | 4.59 M | $86.40 |
| Q4 2016 | -283,430 | Reduce 6.17% | 4.31 M | $71.23 |
| Q1 2017 | -103,859 | Reduce 2.41% | 4.21 M | $80.56 |
| Q2 2017 | +167,133 | Add 3.97% | 4.37 M | $88.75 |
| Q3 2017 | -297,364 | Reduce 6.80% | 4.08 M | $77.77 |
| Q4 2017 | +5,531 | Add 0.14% | 4.08 M | $80.75 |
| Q1 2018 | +365,699 | Add 8.96% | 4.45 M | $80.22 |
| Q2 2018 | -878,183 | Reduce 19.75% | 3.57 M | $85.61 |
| Q3 2018 | -88,227 | Reduce 2.47% | 3.48 M | $98.37 |
| Q4 2018 | +146,896 | Add 4.22% | 3.63 M | $90.96 |
| Q1 2019 | -23,427 | Reduce 0.65% | 3.6 M | $91.08 |
| Q2 2019 | -292,488 | Reduce 8.12% | 3.31 M | $97.39 |
| Q3 2019 | +12,603 | Add 0.38% | 3.32 M | $108.62 |
| Q4 2019 | -25,173 | Reduce 0.76% | 3.3 M | $113.45 |
| Q1 2020 | -52,341 | Reduce 1.59% | 3.25 M | $90.18 |
| Q2 2020 | +1,264 | Add 0.04% | 3.25 M | $91.70 |
| Q3 2020 | -64,931 | Reduce 2.00% | 3.18 M | $103.92 |
| Q4 2020 | -169,212 | Reduce 5.32% | 3.01 M | $117.14 |
| Q1 2021 | -32,127 | Reduce 1.07% | 2.98 M | $118.13 |
| Q2 2021 | -326 | Reduce 0.01% | 2.98 M | $124.13 |
| Q3 2021 | +142,443 | Add 4.78% | 3.12 M | $125.35 |
| Q4 2021 | -4,332 | Reduce 0.14% | 3.12 M | $103.45 |
| Q1 2022 | -7,732 | Reduce 0.25% | 3.11 M | $110.95 |
| Q2 2022 | -121,853 | Reduce 3.92% | 2.99 M | $89.75 |
| Q3 2022 | -10,812 | Reduce 0.36% | 2.98 M | $80.75 |
| Q4 2022 | -112,811 | Reduce 3.79% | 2.87 M | $77.72 |
| Q1 2023 | -13,654 | Reduce 0.48% | 2.85 M | $80.62 |
| Q2 2023 | -2.76 M | Reduce 96.87% | 89,346 | $88.10 |
| Q3 2023 | -56,673 | Reduce 63.43% | 32,673 | $78.36 |
| Q4 2023 | +117,598 | Add 359.92% | 150,271 | $82.38 |
| Q1 2024 | +36,507 | Add 24.29% | 186,778 | $87.15 |
| Q2 2024 | +20,712 | Add 11.09% | 207,490 | $78.71 |
| Q3 2024 | -1,761 | Reduce 0.85% | 205,729 | $90.03 |
| Q4 2024 | +9,646 | Add 4.69% | 215,375 | $79.88 |
| Q1 2025 | -46,433 | Reduce 21.56% | 168,942 | $89.86 |
| Q2 2025 | -101,319 | Reduce 59.97% | 67,623 | $87.17 |
| Q3 2025 | -16,507 | Reduce 24.41% | 51,116 | $95.24 |
Jeremy Grantham's Medtronic plc Investment FAQs
Jeremy Grantham first purchased Medtronic plc (MDT) in Q1 2015, acquiring 7,402,676 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Medtronic plc (MDT) for 43 quarters since Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham's largest addition to Medtronic plc (MDT) was in Q1 2015, adding 7,402,676 shares worth $577.34 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 51,116 shares of Medtronic plc (MDT), valued at approximately $4.87 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Medtronic plc (MDT) represents approximately 0.01% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham's peak holding in Medtronic plc (MDT) was 7,545,614 shares, as reported at the end of Q2 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.